IMPROVEMENT IN CARDIAC-FUNCTION AND EVIDENCE OF INHIBITION OF THE ANGIOTENSIN-ALDOSTERONE SYSTEM AFTER CAPTOPRIL TREATMENT IN PATIENTS WITH REFRACTORY CARDIAC-FAILURE

被引:0
|
作者
DENHAM, IM [1 ]
MCGRATH, BP [1 ]
JOHNSTON, CI [1 ]
机构
[1] PRINCE HENRYS HOSP,MONASH DEPT MED,MELBOURNE,VIC 3004,AUSTRALIA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:639 / 640
页数:2
相关论文
共 50 条
  • [31] LACK OF CORRELATION BETWEEN THE ACUTE HEMODYNAMIC-RESPONSE TO INTRAVENOUS CAPTOPRIL AND PLASMA-CONCENTRATIONS OF ANGIOTENSIN-II IN PATIENTS WITH CHRONIC CARDIAC-FAILURE
    FLAPAN, AD
    SHAW, TRD
    EDWARDS, CRW
    RADEMAKER, M
    DAVIES, E
    WILLIAMS, BC
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (01) : 1 - 5
  • [32] IMPROVEMENT OF RENAL FUNCTION AFTER CARDIAC RESYNCHRONIZATION THERAPY IMPLANTATION IN PATIENTS WITH HEART FAILURE
    Piccone Saponara, Luis Guillermo
    Uribe Heredia, Nancy Giovanna
    Vozmediano Poyatos, Maria Carmen
    Carreno Parrilla, Agustin
    Arroyo Espliguero, Ramon
    Novo Garcia, Enrique
    Moreno Reviriego, Sara
    Jimenez Martinez, Maria Eulalia
    Anaya Fernandez, Sara
    Rivera Hernandez, Francisco
    Balaguer Recena, Javier
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [33] Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)
    Fudim, Marat
    Kelly, Jacob P.
    Brophy, Todd J.
    DeVore, Adam D.
    Hammill, Bradley G.
    Peterson, Eric D.
    Pitt, Bertram
    Yancy, Clyde
    Fonarow, Gregg C.
    Hernandez, Adrian F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (11): : 1655 - 1660
  • [34] Effect of Salidroside on Cardiac Function, Ventricular Remodeling, and Renin-angiotensin-aldosterone System Activity in Rats with Chronic Heart Failure
    Zhang, Bo
    Tong, Tiebi
    Zhou, Jingqun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (12): : 2424 - 2429
  • [35] Correlation between improvement in cardiac function, ventilatory responses to exercise and autonomic control in heart failure patients after cardiac resynchronisation
    Piepoli, M. F.
    Aschieri, D.
    Groppi, F.
    Rosi, A.
    Rusticali, G.
    Vaghini, M.
    Villani, G.
    Capucci, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 171 - 172
  • [36] Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
    Pfeffer, Marc A.
    Claggett, Brian
    Assmann, Susan F.
    Boineau, Robin
    Anand, Inder S.
    Clausell, Nadine
    Desai, Akshay S.
    Diaz, Rafael
    Fleg, Jerome L.
    Gordeev, Ivan
    Heitner, John F.
    Lewis, Eldrin F.
    O'Meara, Eileen
    Rouleau, Jean-Lucien
    Probstfield, Jeffrey L.
    Shaburishvili, Tamaz
    Shah, Sanjiv J.
    Solomon, Scott D.
    Sweitzer, Nancy K.
    McKinlay, Sonja M.
    Pitt, Bertram
    CIRCULATION, 2015, 131 (01) : 34 - +
  • [37] Secondary Prevention of Hyperkalemia With Sodium Polystyrene Sulfonate in Cardiac and Kidney Patients on Renin-Angiotensin-Aldosterone System Inhibition Therapy
    Chernin, Gil
    Gal-Oz, Amir
    Ben-Assa, Eyal
    Schwartz, Idit F.
    Weinstein, Talia
    Schwartz, Doron
    Silverberg, Donald S.
    CLINICAL CARDIOLOGY, 2012, 35 (01) : 32 - 36
  • [38] ACUTE EFFECTS OF INTRAVENOUS NICARDIPINE ON HEMODYNAMICS AND CARDIAC-FUNCTION IN PATIENTS WITH A HEALED MYOCARDIAL-INFARCTION AND NO EVIDENCE OF CONGESTIVE-HEART-FAILURE
    OGAWA, T
    SEKIGUCHI, T
    ISHII, M
    USHIYAMA, K
    YASUI, K
    SUGISHITA, Y
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (04): : 301 - 305
  • [39] RESTORATION OF CARDIAC-FUNCTION AND STRUCTURE BY CONVERTING ENZYME-INHIBITION POSSIBILITIES AND LIMITATIONS OF LONG-TERM TREATMENT IN HYPERTENSION AND HEART-FAILURE
    FOUAD, FM
    TARAZI, RC
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 : S53 - S57
  • [40] Sustained improvement of cardiac function and prevention of cardiac remodeling after long-term dual ECE-NEP inhibition in rats with congestive heart failure
    Mulder, P
    Barbier, S
    Monteil, C
    Jeng, AY
    Henry, JP
    Renet, S
    Thuillez, C
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 43 (04) : 489 - 494